Pharmaceutical packaging company PharmaPack has recently been acquired by international generic pharmaceuticals company Actavis for an undisclosed amount.
Actavis recently bought 100 percent of the shares of the Dutch pharmaceutical packaging company in order to achieve greater flexibility in tender markets and also be able to manufacture, package and pack pharmaceuticals for minimum order quantities to benefit smaller markets.
One of the Dutch company’s future roles will be the bulk packaging of pharmaceuticals produced in the Actavis facility in Alathur (India). Another advantage of this packaging centre will be a significant reduction in freight costs.
“I have known this professional company for a long time and I am very proud that the owners decided to choose Actavis as their new partner. It is obvious that they had other opportunities as well,” explained CEO and Chairman at Actavis, Claudio Albrecht.
Albrecht added, “Actavis buys a considerable amount of tablets from third-party manufacturers. The lead times are sometimes between six and nine months and therefore much too long. With the acquisition of PharmaPack International we are able to reduce these lead times by more than 50 percent.”
Gerard Stevers, Director and owner of PharmaPack International added, “PharmaPack will benefit from the global organisation of Actavis and have great opportunities to grow within this international group…Actavis has very dynamic growth plans for the future and this expansion will have very positive effects for PharmaPack.”
PharmaPack International B.V. is based in Zoetermeer, the Netherlands, and is a specialist in packaging pharmaceutical, as well as biotechnological products. The company has extensive experience with product, organisational and country-specific packaging requirements and has been involved in the pharmaceutical service industry for almost 30 years.
To find out in greater detail about this acquisition, alongside details about the generic pharmaceuticals company, visit www.actavis.com/en.